Celltrion unveils 100 bln-won buyback plan to stabilize stock prices
SEOUL– South Korean biopharmaceutical giant Celltrion Inc. on Monday announced a 100 billion-won (US$83.3 million) share buyback plan to stabilize stock prices and increase its shareholders’ value. Its affiliate, Celltrion…